What is the implantation window and why does timing matter?
The implantation window is a precisely timed period during which the endometrium transitions into a receptive state capable of accepting an embryo. This window opens approximately five to seven days after ovulation or progesterone exposure and remains open for 24 to 48 hours. Outside that window, the endometrium is not receptive regardless of embryo quality.
Standard frozen embryo transfer protocols assume that the implantation window falls at a predictable point in the progesterone-primed cycle. Research shows that the window is displaced in approximately 30 percent of women, meaning standard-timing transfers consistently miss the receptive period even when every other variable is optimized.
The Endometrial Receptivity Analysis (ERA) test uses an endometrial biopsy taken at the standard transfer time to assess whether the endometrium is in a pre-receptive, receptive, or post-receptive state. If the window is displaced, the transfer timing is adjusted by hours or days in a subsequent cycle.
A 2021 randomized controlled trial published in Fertility and Sterility found that personalized embryo transfer timing based on ERA results significantly improved live birth rates in women with a history of recurrent implantation failure, compared to standard-timing transfers in the same patient group.
What is chronic endometritis and why doesn't standard testing find it?
Chronic endometritis is a persistent low-grade bacterial infection of the uterine lining. Unlike acute endometritis, which produces fever and obvious symptoms, chronic endometritis produces no systemic symptoms and returns normal findings on standard ultrasound and hysteroscopy. The only reliable way to detect it is an endometrial biopsy with CD138 immunohistochemical staining, which identifies plasma cells that are the hallmark of chronic endometritis.
Chronic endometritis disrupts implantation by maintaining an activated immune environment in the uterine lining during the implantation window. Instead of the precisely regulated immune state that receptivity requires, the endometrium remains in a state of immune alert that prevents embryo attachment.
Prevalence in fertility populations:
- Present in up to 30 percent of women with unexplained infertility
- Present in up to 42 percent of women with recurrent implantation failure after IVF
- Present in up to 57 percent of women with recurrent pregnancy loss in some study populations
Chronic endometritis is treatable. Antibiotic therapy targeting the causative bacteria, most commonly Enterococcus, Streptococcus, or Enterobacteriaceae, resolves the infection in most cases, with documented improvements in implantation rates after treatment.
A 2018 review in the American Journal of Reproductive Immunology found that treating chronic endometritis before frozen embryo transfer was associated with a 2.4-fold improvement in live birth rates in women with a prior failed transfer.
What does progesterone on transfer day have to do with implantation?
Progesterone on the day of embryo transfer directly determines whether the endometrium is sufficiently primed for implantation. Progesterone drives the endometrial transformation from proliferative to secretory phase, a process that must be complete for the implantation window to open. If progesterone is insufficient on transfer day, the endometrium may not be ready even when the embryo is.
Research consistently links transfer-day progesterone levels to outcomes:
- Progesterone below 10 ng/mL on the day of frozen embryo transfer is associated with significantly reduced clinical pregnancy and live birth rates
- Some studies suggest the optimal threshold is above 15 to 20 ng/mL for frozen transfers using exogenous progesterone
- Progesterone levels in oral or vaginal supplementation protocols vary widely between women due to absorption differences, meaning the prescribed dose does not predict the achieved level
Many clinics do not draw progesterone on transfer day as a standard practice. If a progesterone level was not measured before your transfer, there is no way to know whether the endometrium had adequate progesterone support at the moment the embryo was placed.
A 2019 study in Human Reproduction found that in frozen embryo transfer cycles, progesterone levels on the day of transfer were the strongest single predictor of live birth outcome, outperforming embryo grade as a predictor in that study population.
What is the endometrial microbiome and how does it affect implantation?
The endometrial microbiome is the bacterial community living in the uterine cavity. Until recently the uterus was considered sterile, but research using advanced sequencing has identified a distinct microbial environment in the endometrium that is separate from the vaginal and gut microbiomes and that appears to influence implantation outcomes.
Endometrial microbiome composition and IVF outcomes:
- Lactobacillus-dominant endometrial microbiomes are associated with clinical pregnancy rates of approximately 60 percent in IVF cycles
- Non-Lactobacillus-dominant profiles, where other bacterial species predominate, are associated with clinical pregnancy rates of approximately 23 percent in the same populations
- Specific pathogenic bacteria in the endometrial microbiome, including Gardnerella and Streptococcus, are associated with reduced implantation and higher rates of pregnancy loss
Endometrial microbiome testing is not part of standard fertility workups and is not offered at most clinics. Specialized reproductive immunology centers and some research-focused IVF programs offer endometrial biopsy with microbiome sequencing. This is an emerging area of clinical research with growing evidence but not yet a standard-of-care assessment.
A 2019 study in the American Journal of Obstetrics and Gynecology found that non-Lactobacillus-dominant endometrial microbiomes were independently associated with significantly lower implantation, pregnancy, and live birth rates in women undergoing IVF.
How do I ask my clinic about implantation investigation after failed transfers?
After two or more failed transfers with confirmed good-quality embryos, a targeted implantation investigation is clinically supported and appropriate to request. The most useful approach is to ask specific, named questions rather than a general request for more testing.
Questions to bring to your clinic after unexplained transfer failure:
- “Has my progesterone level been measured on the day of transfer? What was the value, and what is your clinic’s threshold?”
- “Would you recommend ERA testing to assess whether my implantation window is displaced?”
- “Has chronic endometritis been ruled out with an endometrial biopsy and CD138 staining?”
- “Are you assessing uterine natural killer cell density or any immune-mediated implantation factors?”
If your clinic does not offer ERA, endometrial biopsy with CD138 staining, or NK cell assessment, asking for a referral to a reproductive immunologist or a clinic with an implantation failure program is appropriate. These are not experimental requests. ERA and chronic endometritis biopsy are supported by published clinical guidelines for recurrent implantation failure.
According to the European Society of Human Reproduction and Embryology, implantation failure investigation including endometrial assessment is recommended after two or more failed transfers of good-quality embryos.
The The Fertility Intelligence Hub Perspective
The uterine environment is half the equation. Most workups only look at one half.
When a transfer fails, the first question most clinics ask is about the embryo. Was it euploid? What was the grade? And those are important questions. But the embryo is only half of the implantation equation.
The other half is the environment the embryo is transferred into. The timing of the window. The immune state of the endometrium. Whether there is a low-grade infection that standard imaging cannot see. Whether progesterone was actually sufficient on the day of transfer. These are solvable questions with available tools, and most of them are not being asked as a matter of routine.
Fertility Block Mapping takes both halves seriously. When I work with a client who has had repeated transfer failures with good embryos, the investigation always extends into the uterine environment. That is where the answers often are.
Implantation failure is not always about the embryo. Sometimes it is about the timing. Sometimes it is about a silent infection. Sometimes it is about progesterone support that looked adequate on paper but was not adequate in practice. Each of these is identifiable with the right question and the right test.
You are allowed to ask why. And you are allowed to keep asking until the answer is complete.
